Receptors for advanced glycation end-products targeting protect against hyperoxia-induced lung injury in mice

American Journal of Respiratory Cell and Molecular Biology

Volumn 42, Issue 5, 2010, Pages 545-551

  Reynolds, Paul R ^a,b   Schmitt, Robert E ^a   Kasteler, Stephen D ^a   Sturrock, Anne ^a   Sanders, Karl ^a   Bierhaus, Angelika ^c   Nawroth, Peter P ^c   Paine III, Robert ^a   Hoidal, John R ^a  

^a UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

^b BRIGHAM YOUNG UNIVERSITY   (United States)

^c UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Acute lung injury; Hyperoxia; Inflammation; Receptors for advanced glycation end products

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; CYTOKINE; EOSIN; HEMATOXYLIN; ADVANCED GLYCOSYLATION END PRODUCT RECEPTOR; ADVANCED GLYCOSYLATION END-PRODUCT RECEPTOR; AUTACOID; IMMUNOGLOBULIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY DETECTION; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; DRY WEIGHT; FEMALE; HYPEROXIA; HYPOTHESIS; IMMUNOHISTOCHEMISTRY; LUNG ALVEOLUS; LUNG ALVEOLUS EPITHELIUM; LUNG INJURY; LUNG LAVAGE; NONHUMAN; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SURVIVAL; WILD TYPE; ANIMAL; C57BL MOUSE; CELL CULTURE; CYTOLOGY; LUNG ALVEOLUS CELL; METABOLISM; MOUSE; MOUSE MUTANT; PATHOLOGY;

ANIMALIA; MUS;

ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; CELLS, CULTURED; FEMALE; HYPEROXIA; INFLAMMATION MEDIATORS; LUNG INJURY; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PNEUMOCYTES; RECEPTORS, IMMUNOLOGIC; SURVIVAL ANALYSIS;

EID: 77951636781     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2008-0265OC     Document Type: Article

References (35)

1. Rubenfeld GD, Caldwell E, Peabody E, Weaver J, Martin DP, Neff M, Stern EJ, Hudson LD. Incidence and outcomes of acute lung injury. N Engl J Med 2005;353:1685-1693.
2. Dos Santos CC. Hyperoxic acute lung injury and ventilator-induced/ associated lung injury: new insights into intracellular signaling pathways. Crit Care 2007;11:126.
3. Mantell LL, Horowitz S, Davis JM, Kazzaz JA. Hyperoxia-induced cell death in the lung-the correlation of apoptosis, necrosis, and inflammation. Ann N Y Acad Sci 1999;887:171-180.
4. Thornally PJ. Cell activation by glycated proteins: AGE receptors, receptor recognition factors and functional classsification of AGEs. Cell Mol Biol (Noisy-le-grand) 1998;44:1013-1023.
5. Reynolds PR, Ksteler SD, Cosio MG, Sturrock A, Huecksteadt TP, Hoidal RAGE Jr. developmental expression and positive feedback regulation by Egr-1 during cigarette smoke exposure in pulmonary epithelial cells. Am J Physiol Lung Cell Mol Physiol 2008;294:L1094-L1101.
6. Schmidt AM, Yan SD, Yan SF, Stern DM. The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. J Clin Invest 2001;108:949-955.
7. Hofmann MA, Drury S, Fu C, Qu W, Taguchi A, Lu Y, Avila C, Kambham N, Bierhaus A, Nawroth P. RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 1999;97:889-901.
8. Taguchi A, Blood DC, del Toro G, Canet A, Lee DC, Qu W, Tanji N, Lu Y, Lalla E, Fu C. Blockade of amphoterin/RAGE signalling suppresses tumor growth and metastases. Nature 2000;405:354-360.
9. Yan SD, Chen X, Fu J, Chen M, Zhu H, Roher A, Slattery T, Nagashima M, Morser J, Migheli A. RAGE and amyloid beta peptide neurotoxicity in Alzheimer's disease. Nature 1996;382:685-691.
10. Sternberg DI, Gowda R, Mehra D, Qu W, Weinberg A, Twaddell W, Sarkar J, Wallace A, Hudson B, D'Ovidio F, et al. Blockade of receptor fir advanced glycation end product attenuates pulmonary reperfusion injury in mice. J Thorac Cardiovasc Surg 2008;136:1576-1585.
11. Calfee CS, Ware LB, Eisner MD, Pasrons PE Thompson BT, Wickersham N, Matthay MA; NHLBI ARDS Network. Plasma receptor for advanced glycation end products and clinical outcomes in acute lung injury. Thorax 2008;63:1083-1089.
12. Zhang H, Tasaka S, Shiraishi Y, Fukunaga K, Yamada W, Seki H, Ogawa Y, Miyamoto K, Nakano Y, Hasegawa N, et al. Role of soluble receptor for advanced glycation end products on endotoxin-induced lung injury. Am J Respir Crit Care Med 2008;178:356-362.
13. Queisser MA, Kouri FM, Konigshoff M, Wygrecka M, Schubert U, Eickelberg O, Preissner KT. Loss of RAGE in pulmonary fibrosis: molecular relations to functional changes in pulmonary cell types. Am J Respir Cell Mol Biol 2008;39:337-345.
14. Englert JM, Hanford LE, Kaminski N, Tobolewski JM, Tan RJ, Fattman CL, Ramsgaard L, Richards TJ, Loutaev I, Nawroth PP, et al. A role for the receptor for advanced glycation end products in idiopathic pulmonary fibrosis. Am J Pathol 2008;172:583-591.
15. Wendt TM, Tanji N, Guo J, Kislinger TR, Qu W, Lu Y, Bucciarelli LG, Rong LL, Moser B, Markowitz GS, et al. RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic neuropathy. Am J Pathol 2003;162:1123-1137.
16. Reynolds PR, Mucenski ML, Le Cras TD, Nichols WC, Whitsett JA. Midkine is regulated by hypoxia and causes pulmonary vascular remodeling. J Biol Chem 2004;279:37124-37132.
17. Paine R III, Wilcoxen SE, Morris SB, Sartori C, Baleeiro CE, Matthay MA, Christensen PJ. Transgenic overexpression of granulocyte macrophage-colony stimulating factor in the lung prevents hyperoxia lung injury. Am J Pathol 2003;163:2397-2406.
18. Heffner JE, Repine JE. Pulmonary strategies of antioxidant defense. Am Rev Respir Dis 1989;140:531.
19. Watkins RH, D'Angio CT, Ryan RM, Patel A, Maniscalco WM. Differential expression of VEGF mRAN splice variants in newborn and adult hyperoxic lung injury. Am J Physiol 1999;276:L858.
20. Rovai LE, Herschman HR, Smith JB. Cloning and characterization of the human granulocyte chemotactic protein-2 gene. J Immunol 1997;158:5257-5266.
21. Smith JB, Rovai LE, Herschman HR. Sequence similarities of a subgroup of CXC chemokines related to murine LIX: implications for the interpretation of evolutionary relationships among chemokines. J Leukoc Biol 1997;62:598-603.
22. Smith JB, Wadleigh DJ, Xia YR, Mar RA, Herschman HR, Lusis AJ. Cloning and genomic localization of the murine LPS-induced CXC chemokine (LIX) gene, Scyb5. Immunogenetics 2002;54:599-603.
23. Jeyaseelans S, Chu HW, Young SK, Worthen GS. Transcriptional profiling of lipopolysaccharide-induced acute lung injury. Infect Immun 2004;72:7247-7256.
24. Parsons PE, Matthay MA, Ware LB, and Eisner MD. Elevated plasma levels of soluble TNF receptors are associated with morbidity and mortality in patients with acute lung injury. Am J Physiol Lung Cell Mol Physiol 2005;288:L426-L431.
25. Moreau E, Phillipe J, Couvent S, Leroux-Roels G. Interference of sTNF-alpha receptors in immunological detection of tumor necrosis factor-alpha. Clin Chem 1996;42:1450-1453.
26. Wang W, Bacon KB, Oldham ER, Schall TJ. Molecular cloning and functional characterization of human MIP-1γ, a new C-C chemokine related to mouse CCF-18 and C10. J Clin Immunol 1998;18:214-224.
27. Matsushima K, Larsen CG, DuBois GC, Oppenheim JJ. Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line. J Exp Med 1989;169:1485-1490.
28. Wang H, Bloom O, Zhang M, Vishnubhakat JM, Ombrellino M, Che J, Frazier A, Yang H, Ivanova S, Borovikova L, et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science 1999;285:248-251.
29. Anderson KV. Toll signaling pathways in the innate immune response. Curr Opin Immunol 2000;12:13-19.
30. Fiuza C, Bustin M, Talwar S, Tropea M, Gerstenberger E, Shelhamer JH, Suffredini AF. Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells. Blood 2003;101:2652-2660. (Pubitemid 36857626)
31. Abraham E, Arcaroli J, Carmody A, Wang H, Tracey KJ. HMG-1 as amediator of acute lung inflammation. J Immunol 2000;165:2950-2954.
32. Fox RB, Hoidal JR, Brown DM, Repine JE. Pulmonary inflammation due to oxygen toxicity: involvement of chemotactic factors and polymorphonuclear leukocytes. Am Rev Respir Dis 1981;123:521-523.
33. Lizotte PP, Hanford LE, Enghild JJ, Nozik-Grayck E, Giles B, Oury TD. Developmental expression of the receptor for advanced glycation end products (RAGE) and its response to hyperoxia in the neonatal rat lung. BMC Dev Biol 2007;7:15. (Pubitemid 46426273)
34. Uchida T, Shirasawa M, Ware LB, Kojima K, Hata Y, Mikata K, Mednick G, Matthay ZA, Matthay MA. Receptor for advanced glycation end products is a marker of type I cell injury in acute lung injury. Am J Respir Crit Care Med 2006;173:1008-1015.
35. Briot R, Frank JA, Uchida T, Lee JW, Calfee CS, Matthay MA. Elevated levels of the receptor for advanced glycation end products, a marker of alveolar epithelial type I cell injury, predict impaired alveolar fluid clearance in isolated perfused human lungs. Chest 2009;135:269-275.